Replies to post #469997 on NorthWest Biotherapeutics Inc (NWBO)

[VuBru]

Buried in the NYAS communications was the mention that the talk today could not be posted for on demand download because they have a publication under review. This is the first confirmation that a paper has been submitted. So, hopefully an accepted publication will be announced in the fairly near future. The reception at ASCO in a month will be very interesting (I would think oncologists would be very impressed by the doubling in rates of extended survival in this deadly disease).

[ilovetech]

Bioinvest., The manipulators we're ready and prepared regardless of how the data was released. The market has proven to be gullible in my opinion, and the key sections of a release are the glaring graphical representations, interpretations, summary, and finally conclusions. The release hit all those marks. I don't know if the average investor, retail heavy in this case, would fare any better to have their fears alleviated, because I just don't see them reading through complex medical jargon. These are the kinds of people who rather have others do it for them. So perhaps it's better to have the unsophisticated get out of the way, and enjoy watching the big boys start piling in, as they don't depend on fake news.

JMHO
ILT

[Kgeo]

Yup. They have been waiting 18 months for this day. Disseminating information to a small audience behind a paywall was not best choice. Also giving 4 days to coordinate. I certainly hope a public PR and the journal is following very closely.

[Hopeforthefuture3]

Bio, imo I agree this announcement was poorly handled, I put it down to lack of experience of the nwbo management